(1R,3s,5S)-rel-3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane - CAS 423165-07-5
Catalog: |
BB025103 |
Product Name: |
(1R,3s,5S)-rel-3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane |
CAS: |
423165-07-5 |
Synonyms: |
(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane; (1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane |
IUPAC Name: | (1S,5R)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane |
Description: | A metabolite of Maraviroc. |
Molecular Weight: | 234.34 |
Molecular Formula: | C13H22N4 |
Canonical SMILES: | CC1=NN=C(N1C2CC3CCC(C2)N3)C(C)C |
InChI: | InChI=1S/C13H22N4/c1-8(2)13-16-15-9(3)17(13)12-6-10-4-5-11(7-12)14-10/h8,10-12,14H,4-7H2,1-3H3/t10-,11+,12? |
InChI Key: | CEIRCCADSFHOQD-FOSCPWQOSA-N |
Density: | 1.31 g/cm3 |
LogP: | 2.49420 |
Publication Number | Title | Priority Date |
US-10556899-B2 | Method for preparing Maraviroc | 20180209 |
US-2019248782-A1 | Method for preparing maraviroc | 20180209 |
AU-2017333548-B2 | Method for synthesizing novel chiral ligand, metal chelate, a variety of non-natural amino acids, maraviroc and key intermediate thereof | 20160929 |
EP-3521274-A1 | Method for synthesizing novel chiral ligand, metal chelate, a variety of non-natural amino acids, maraviroc and key intermediate thereof | 20160929 |
US-2019233456-A1 | Method for synthesizing novel chiral ligand, metal chelate, a variety of non-natural amino acids, maraviroc and key intermediate thereof | 20160929 |
Complexity: | 269 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 2 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 234.18444672 |
Formal Charge: | 0 |
Heavy Atom Count: | 17 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 234.18444672 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 42.7 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.6 |
-
Catalog: BB045655
((5-[(4-Chloro-3-methyl-1H-pyrazol-1-yl)methyl]-4-ethyl-4H-1,2,4-triazol-3-yl)thio)acetic acid
Detail
-
Catalog: BB043308
(5AR,10BS)-(+)-5A,10B-DIHYDRO-2-(PENTAFLUOROPHENYL)-4H,6H-INDENO[2,1-B][1,2,4]TRIZOLO[4,3-D][1,4]OXAZINIUM TETRAFLUOROBORATE
Detail
-
Catalog: BB051405
(3-Bromo-1H-1,2,4-triazol-1-yl)methanol
Detail
-
Catalog: BB042748
(5aR,10bS)-5a,10b-dihydro-2-(2,4,6-trichlorophenyl)-4H,6H-Indeno[2,1b][1,2,4]triazolo[4,3-d][1,4]oxazinium tetrafluoroborate
Detail
-
Catalog: BB049236
(3-Amino-1H-1,2,4-triazol-1-yl)acetic acid
Detail
-
Catalog: BB045371
(5-Amino-2H-tetrazol-2-yl)acetic acid
Detail
-
Catalog: BB037166
([1,2,4]Triazolo[4,3-b]pyridazin-6-yloxy)acetic acid
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Triazole/Tetrazole
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS